Peter Myrenfors
About
In The Last Decade
Peter Myrenfors
13 papers receiving 340 citations
Peers
Comparison fields: 5 of 53
- Surgery 200
- Physiology 140
- Cardiology and Cardiovascular Medicine 118
- Endocrinology, Diabetes and Metabolism 82
- Oncology 44
Countries citing papers authored by Peter Myrenfors
This map shows the geographic impact of Peter Myrenfors's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Myrenfors with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Myrenfors more than expected).
Fields of papers citing papers by Peter Myrenfors
This network shows the impact of papers produced by Peter Myrenfors. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Myrenfors. The network helps show where Peter Myrenfors may publish in the future.
Co-authorship network of co-authors of Peter Myrenfors
This figure shows the co-authorship network connecting the top 25 collaborators of Peter Myrenfors. A scholar is included among the top collaborators of Peter Myrenfors based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Myrenfors. Peter Myrenfors is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 8 | |
| 3 | 8 | |
| 4 | 6 | |
| 5 | 1 | |
| 6 | STREET - Somatostatin Treatment Experience Trial | 2 |
| 7 | 8 | |
| 8 | 71 | |
| 9 | 224 | |
| 10 | 5 | |
| 11 | [Ten cases of poisoning with gamma hydroxybutyrate. An endogenous substance used by body builders]. | 3 |
| 12 | 19 | |
| 13 | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.